| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |